Non-alcoholic fatty liver disease is associated with progression of arterial stiffness

被引:36
|
作者
Li, N. [1 ]
Zhang, G. -W. [2 ]
Zhang, J. -R. [3 ]
Jin, D. [3 ]
Li, Y. [3 ,4 ]
Liu, T. [5 ]
Wang, R. -T. [3 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 2, Dept Cardiol, Harbin 150086, Heilongjiang, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Harbin 150086, Heilongjiang, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 2, Dept Geriatr, Harbin 150086, Heilongjiang, Peoples R China
[4] Harbin Med Univ, Affiliated Hosp 2, Int Phys Examinat & Healthy Ctr, Harbin 150086, Heilongjiang, Peoples R China
[5] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA
关键词
Non-alcoholic fatty liver disease; Brachial-ankle pulse wave velocity; Arterial stiffness; PULSE-WAVE VELOCITY; EPICARDIAL ADIPOSE-TISSUE; C-REACTIVE PROTEIN; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; RISK-FACTOR; INDIVIDUALS; MORTALITY; CHINESE; COHORT;
D O I
10.1016/j.numecd.2014.10.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: NAFLD is an independent risk factor for increased cardiovascular disease. Arterial stiffness is an index of subclinical atherosclerosis. The aims of this study were to examine prospectively the relationship between Non-alcoholic fatty liver disease (NAFLD) and the progression of arterial stiffness. Methods and results: A prospective study of 728 men and 497 women free of hypertension, and diabetes at the baseline were conducted. The subjects were followed for 5 years. The progression rate of arterial stiffness was measured by calculating the increase in brachial-ankle pulse wave velocity (baPWV) the changes of the baPWV (adjusted for age) during the study period was significantly greater in the patients with NAFLD (172.4 +/- 42.1 cm/s for men, 95.8 +/- 36.7 cm/s for women) than in the subjects without NAFLD (70.3 +/- 56.5 cm/s for men, 55.4 +/- 42.2 cm/s for women). For the subjects with metabolic syndrome, after adjusting for multiple risk factors, NAFLD was a significant predictor of baPWV progression (for male, beta = 0.843; P < 0.001; for female, beta = 0.575; P < 0.001, respectively). In addition, results were unmodified in subjects without metabolic syndrome. Conclusions: NAFLD was found to be an independent predictor of faster progression of baPWV even after adjusting other cardiovascular risk factors. These prospective data support a pathogenic role for NAFLD in the development of arterial stiffness. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:218 / 223
页数:6
相关论文
共 50 条
  • [21] Relationship between non-alcoholic fatty liver disease, vascular risk factors and arterial stiffness in adolescents
    Chinnaratha, Mohamed A.
    Le-Ha, Chi
    Beilin, Lawrie
    Ayonrinde, Oyekoya T.
    Olynyk, John K.
    Mori, Trevor
    Burrows, Sally
    Pennell, Craig
    Adams, Leon A.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A33 - A34
  • [22] Carnitine signature in liver corretales with non-alcoholic fatty liver disease progression
    Jimenez Franco, Andrea
    Castane, Helena
    Baiges Gaya, Gerard
    Rodriguez-Tomas, Elisabet
    Camps Andreu, Jordi
    Joven Maried, Jorge
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S681 - S681
  • [23] Non-alcoholic fatty liver disease
    Powell, Elizabeth E.
    Wong, Vincent Wai-Sun
    Rinella, Mary
    [J]. LANCET, 2021, 397 (10290): : 2212 - 2224
  • [24] Non-alcoholic fatty liver disease
    Cua, IHY
    George, J
    [J]. HOSPITAL MEDICINE, 2005, 66 (02): : 106 - 111
  • [25] Non-alcoholic fatty liver disease
    Bjornsson, Einar
    Angulo, Paul
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2007, 42 (09) : 1023 - 1030
  • [26] Non-alcoholic Fatty Liver Disease
    Tan, Hui-Hui
    Chang, Jason Pik-Eu
    [J]. PROCEEDINGS OF SINGAPORE HEALTHCARE, 2010, 19 (01) : 36 - 50
  • [27] Non-alcoholic fatty liver disease
    Angulo, P
    Lindor, KD
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 : S186 - S190
  • [28] Non-alcoholic fatty liver disease
    Tuyama, Ana C.
    Chang, Charissa Y.
    [J]. JOURNAL OF DIABETES, 2012, 4 (03) : 266 - 280
  • [29] Non-alcoholic fatty liver disease
    Neuschwander-Tetri, Brent A.
    [J]. BMC MEDICINE, 2017, 15
  • [30] Non-alcoholic fatty liver disease
    Carreras, MP
    Tortajada, GC
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2005, 97 (05) : 377 - 377